Clinical Trial Update: Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity

View source ↗

Summary

The update reports on a completed study investigating interleukin-6 in plaque psoriasis and its potential link to disease severity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Snippet

Sponsor: Tanta University | Conditions: Interleukin-6, Plaque Psoriasis | Status: COMPLETED